First Time Loading...

Taisho Pharmaceutical Holdings Co Ltd
TSE:4581

Watchlist Manager
Taisho Pharmaceutical Holdings Co Ltd Logo
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Watchlist
Price: 999 999.9999 JPY Market Closed
Updated: Apr 28, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

320.4B
+0.1%
Revenue
Growth Rates:
1 Year
+8%
3 Years
+10%
5 Years
+21%
7 Years
+14%
10 Years
+9%
18.9B
-30%
Operating Income
Growth Rates:
1 Year
-29%
3 Years
-24%
5 Years
-48%
7 Years
-42%
10 Years
-54%
8.4B
-46%
Net Income
Growth Rates:
1 Year
-66%
3 Years
-49%
5 Years
-85%
7 Years
-69%
10 Years
-74%

Earnings Waterfall
Taisho Pharmaceutical Holdings Co Ltd

Revenue
320.4B JPY
Cost of Revenue
-137.2B JPY
Gross Profit
183.2B JPY
Operating Expenses
-164.3B JPY
Operating Income
18.9B JPY
Other Expenses
-10.5B JPY
Net Income
8.4B JPY

Income Statement
Taisho Pharmaceutical Holdings Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
292 838
N/A
295 957
+1%
296 150
+0%
293 199
-1%
289 777
-1%
290 498
+0%
291 339
+0%
294 677
+1%
293 717
0%
290 135
-1%
290 354
+0%
285 158
-2%
281 588
-1%
279 773
-1%
278 874
0%
277 396
-1%
279 140
+1%
280 092
+0%
273 308
-2%
270 953
-1%
264 190
-2%
261 551
-1%
260 063
-1%
264 268
+2%
272 993
+3%
288 527
+6%
303 290
+5%
302 219
0%
291 489
-4%
281 980
-3%
270 841
-4%
266 241
-2%
267 731
+1%
268 203
+0%
273 388
+2%
282 560
+3%
295 821
+5%
301 381
+2%
313 114
+4%
319 960
+2%
320 385
+0%
Gross Profit
Cost of Revenue
(110 414)
(111 275)
(110 871)
(110 482)
(110 949)
(112 240)
(113 819)
(115 725)
(115 715)
(113 143)
(111 480)
(107 197)
(103 114)
(101 525)
(100 725)
(99 299)
(98 124)
(97 154)
(94 217)
(92 994)
(91 680)
(91 206)
(88 948)
(91 328)
(99 223)
(108 386)
(117 186)
(116 372)
(108 783)
(106 050)
(102 357)
(105 318)
(106 373)
(104 371)
(107 491)
(110 919)
(117 834)
(123 531)
(128 789)
(133 248)
(137 220)
Gross Profit
182 424
N/A
184 682
+1%
185 279
+0%
182 717
-1%
178 828
-2%
178 258
0%
177 520
0%
178 952
+1%
178 002
-1%
176 992
-1%
178 874
+1%
177 961
-1%
178 474
+0%
178 248
0%
178 149
0%
178 097
0%
181 016
+2%
182 938
+1%
179 091
-2%
177 959
-1%
172 510
-3%
170 345
-1%
171 115
+0%
172 940
+1%
173 770
+0%
180 141
+4%
186 104
+3%
185 847
0%
182 706
-2%
175 930
-4%
168 484
-4%
160 923
-4%
161 358
+0%
163 832
+2%
165 897
+1%
171 641
+3%
177 987
+4%
177 850
0%
184 325
+4%
186 712
+1%
183 165
-2%
Operating Income
Operating Expenses
(141 414)
(142 999)
(144 036)
(146 312)
(148 778)
(146 284)
(148 931)
(149 296)
(148 153)
(148 114)
(146 975)
(147 204)
(145 758)
(146 282)
(148 347)
(147 607)
(147 055)
(145 961)
(140 897)
(139 169)
(135 972)
(139 134)
(139 737)
(144 195)
(153 589)
(159 004)
(163 902)
(162 940)
(157 791)
(155 965)
(155 232)
(154 940)
(155 124)
(153 089)
(153 527)
(151 004)
(151 253)
(154 832)
(157 488)
(159 541)
(164 254)
Selling, General & Administrative
(141 329)
(121 135)
(144 120)
(146 317)
(148 750)
(124 719)
(148 809)
(148 975)
(147 719)
(126 167)
(146 008)
(146 433)
(146 074)
(125 000)
(148 316)
(146 962)
(146 599)
(124 857)
(141 038)
(139 937)
(136 567)
(118 150)
(139 543)
(144 053)
(153 463)
(136 320)
(164 053)
(163 063)
(157 786)
(135 770)
(155 246)
(154 952)
(155 287)
(133 722)
(152 575)
(151 004)
(151 252)
(134 104)
(157 487)
(159 539)
(164 253)
Research & Development
0
(21 874)
0
0
0
(21 554)
0
0
0
0
0
0
0
(21 260)
0
0
0
(21 150)
0
0
0
(20 801)
0
0
0
(22 876)
0
0
0
(20 251)
0
0
0
(19 366)
0
0
0
(20 727)
0
0
0
Other Operating Expenses
(85)
10
84
5
(28)
(11)
(122)
(321)
(434)
(21 947)
(967)
(771)
316
(22)
(32)
(646)
(456)
46
140
768
595
(183)
(194)
(142)
(126)
192
151
123
(5)
56
14
12
163
(1)
(952)
0
(1)
(1)
(1)
0
(1)
Operating Income
41 010
N/A
41 683
+2%
41 243
-1%
36 405
-12%
30 050
-17%
31 974
+6%
28 589
-11%
29 656
+4%
29 849
+1%
28 878
-3%
31 899
+10%
30 757
-4%
32 716
+6%
31 966
-2%
29 802
-7%
30 490
+2%
33 961
+11%
36 977
+9%
38 194
+3%
38 790
+2%
36 538
-6%
31 211
-15%
31 378
+1%
28 745
-8%
20 181
-30%
21 137
+5%
22 202
+5%
22 907
+3%
24 915
+9%
19 965
-20%
13 252
-34%
5 983
-55%
6 234
+4%
10 743
+72%
12 370
+15%
20 637
+67%
26 734
+30%
23 018
-14%
26 837
+17%
27 171
+1%
18 911
-30%
Pre-Tax Income
Interest Income Expense
8 412
9 025
8 757
8 250
7 679
6 943
6 970
7 336
7 224
7 211
6 390
7 367
9 405
9 554
10 072
8 363
11 416
10 128
11 990
12 634
7 292
8 536
4 260
3 603
4 462
3 146
5 382
5 211
3 458
5 578
5 502
7 540
10 943
11 873
14 443
13 007
9 125
7 105
5 281
4 802
5 776
Non-Reccuring Items
0
1
(39)
(40)
(40)
(52)
0
0
0
(851)
0
0
(850)
1
0
0
1
1
0
(12 189)
(12 875)
(19 268)
(13 175)
(984)
(891)
5 502
(744)
(745)
(153)
(2 404)
(2 252)
(2 212)
(2 213)
(952)
0
(1 021)
(1 019)
(1 567)
(5 579)
(7 554)
(7 651)
Gain/Loss on Disposition of Assets
1 108
15
(64)
691
648
639
592
(167)
(108)
0
(104)
(106)
(110)
(170)
645
640
627
331
(403)
42 569
42 580
42 901
42 899
(173)
(168)
(201)
(344)
(401)
0
(499)
(268)
(151)
(160)
(132)
(140)
(92)
718
620
639
620
(262)
Total Other Income
696
592
589
601
590
658
724
664
697
571
562
619
608
605
627
623
673
633
963
1 175
1 094
1 104
659
402
318
191
357
607
57
336
(72)
(308)
(477)
(134)
(69)
(128)
227
322
208
207
310
Pre-Tax Income
51 226
N/A
51 316
+0%
50 486
-2%
45 907
-9%
38 927
-15%
40 162
+3%
36 875
-8%
37 489
+2%
37 662
+0%
35 809
-5%
38 747
+8%
38 637
0%
41 769
+8%
41 956
+0%
41 146
-2%
40 116
-3%
46 678
+16%
48 070
+3%
50 744
+6%
82 979
+64%
74 629
-10%
64 484
-14%
66 021
+2%
31 593
-52%
23 902
-24%
29 775
+25%
26 853
-10%
27 579
+3%
28 277
+3%
22 976
-19%
16 162
-30%
10 852
-33%
14 327
+32%
21 398
+49%
26 604
+24%
32 403
+22%
35 785
+10%
29 498
-18%
27 386
-7%
25 246
-8%
17 084
-32%
Net Income
Tax Provision
(17 356)
(17 305)
(17 018)
(15 643)
(13 098)
(14 102)
(12 946)
(12 783)
(12 607)
(11 927)
(12 419)
(12 433)
(12 809)
(11 750)
(12 382)
(11 623)
(13 890)
(14 701)
(9 334)
(19 194)
(16 564)
(14 658)
(18 961)
(9 910)
(7 884)
(8 245)
(9 961)
(8 602)
(9 418)
(7 782)
(5 953)
(4 119)
(4 591)
(6 448)
(7 043)
(9 412)
(8 602)
(8 196)
(7 093)
(6 943)
(6 167)
Income from Continuing Operations
33 870
34 011
33 468
30 264
25 829
26 060
23 929
24 706
25 055
23 882
26 328
26 204
28 960
30 206
28 764
28 493
32 788
33 369
41 410
63 785
58 065
49 826
47 060
21 683
16 018
21 530
16 892
18 977
18 859
15 194
10 209
6 733
9 736
14 950
19 561
22 991
27 183
21 302
20 293
18 303
10 917
Income to Minority Interest
(1 558)
(1 317)
(1 526)
(1 493)
(1 334)
(1 531)
(1 373)
(1 490)
(1 461)
(1 408)
(1 594)
(1 511)
(1 521)
(1 424)
(1 392)
(1 195)
(1 213)
(1 689)
(1 577)
(1 687)
(1 451)
(1 231)
(1 146)
(737)
(1 027)
(1 356)
(1 661)
(2 293)
(2 243)
(1 878)
(1 779)
(1 803)
(1 681)
(1 828)
(1 866)
(1 900)
(2 137)
(2 305)
(2 684)
(2 733)
(2 495)
Net Income (Common)
32 311
N/A
32 692
+1%
31 940
-2%
28 769
-10%
24 493
-15%
24 528
+0%
22 556
-8%
23 216
+3%
23 593
+2%
22 473
-5%
24 732
+10%
24 691
0%
27 438
+11%
28 781
+5%
27 370
-5%
27 298
0%
31 574
+16%
31 679
+0%
39 834
+26%
62 097
+56%
56 614
-9%
48 593
-14%
45 910
-6%
20 943
-54%
14 988
-28%
20 172
+35%
15 230
-24%
16 682
+10%
16 614
0%
13 316
-20%
8 431
-37%
4 930
-42%
8 055
+63%
13 122
+63%
17 694
+35%
21 091
+19%
25 047
+19%
18 997
-24%
17 609
-7%
15 570
-12%
8 421
-46%
EPS (Diluted)
398.9
N/A
403.6
+1%
394.32
-2%
355.17
-10%
302.38
-15%
302.41
+0%
278.46
-8%
286.61
+3%
291.27
+2%
277.6
-5%
309.14
+11%
308.63
0%
342.97
+11%
359.93
+5%
342.12
-5%
341.22
0%
394.67
+16%
396.23
+0%
497.92
+26%
777.26
+56%
709.29
-9%
608.23
-14%
574.65
-6%
262.09
-54%
187.58
-28%
252.46
+35%
190.61
-24%
208.77
+10%
207.9
0%
166.63
-20%
105.51
-37%
60.06
-43%
98.12
+63%
160.93
+64%
215.57
+34%
256.95
+19%
305.13
+19%
231.42
-24%
214.51
-7%
189.66
-12%
102.57
-46%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.